• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 NINDS 试验中招募女性和少数族裔。

Enrollment of women and minorities in NINDS trials.

机构信息

Stroke Program, University of Michigan Medical School, Ann Arbor, MI 48109-5855, USA.

出版信息

Neurology. 2011 Jan 25;76(4):354-60. doi: 10.1212/WNL.0b013e3182088260. Epub 2011 Jan 5.

DOI:10.1212/WNL.0b013e3182088260
PMID:21209376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3034419/
Abstract

OBJECTIVE

To determine policy-associated changes over time in 1) the enrollment of women and minorities in National Institute of Neurological Disorders and Stroke (NINDS)-funded clinical trials and 2) the trial publication reporting of race/ethnicity and gender.

METHODS

All NINDS-funded phase III trials published between 1985 and 2008 were identified. Percent of African Americans, Hispanic Americans, and women enrolled in the trials was calculated for those trials with available data. Z tests were used to compare reporting and enrollment data from before (period 1) and after (period 2) 1995 when NIH enacted their policies regarding race, ethnicity, and gender. Percent of main trial publications reporting enrollment of African Americans, Hispanic Americans, and women was also calculated.

RESULTS

Of the 56 trials identified, 100%, 48%, and 25% reported enrollment by gender, race, and ethnicity. Women constituted 42.1% of the trial population. Enrollment of women increased over time (36.9% period 1; 49.0% period 2, p < 0.001). African Americans constituted 19.8% of the enrollees in trials with available data and enrollment increased over time (11.6% period 1; 30.7% period 2, p < 0.001). Hispanic Americans constituted 5.8% of subjects in trials with available data and enrollment decreased over time (7.4% period 1; 5.0% period 2, p < 0.001).

CONCLUSIONS

Improvements in reporting of race/ethnicity in publications and enrollment of Hispanics in NINDS trials are needed. While African American representation is above population levels, Hispanic Americans are underrepresented in NINDS trials and representation is declining despite Hispanics' increasing representation in the US population.

摘要

目的

确定 1)国家神经疾病与卒中研究所(NINDS)资助的临床试验中女性和少数族裔的入组情况,以及 2)种族/民族和性别报告在临床试验中的变化趋势是否与政策相关。

方法

确定了 1985 年至 2008 年间发表的所有 NINDS 资助的 III 期临床试验。对于有可用数据的试验,计算了试验中纳入的非裔美国人、西班牙裔美国人和女性的百分比。采用 Z 检验比较了 1995 年 NIH 制定有关种族、民族和性别政策之前(第 1 期)和之后(第 2 期)的报告和入组数据。还计算了主要试验出版物报告纳入非裔美国人、西班牙裔美国人和女性的百分比。

结果

在确定的 56 项试验中,有 100%、48%和 25%报告了性别、种族和民族的入组情况。女性占试验人群的 42.1%。女性入组人数随时间增加(第 1 期 36.9%;第 2 期 49.0%,p<0.001)。在有可用数据的试验中,非裔美国人占入组人数的 19.8%,且入组人数随时间增加(第 1 期 11.6%;第 2 期 30.7%,p<0.001)。在有可用数据的试验中,西班牙裔美国人占受试者的 5.8%,且入组人数随时间减少(第 1 期 7.4%;第 2 期 5.0%,p<0.001)。

结论

需要改进出版物中种族/民族的报告和 NINDS 试验中西班牙裔美国人的入组情况。虽然非裔美国人的代表性高于人口水平,但西班牙裔美国人在 NINDS 试验中的代表性不足,而且尽管西班牙裔在美国人口中的比例不断增加,但代表性却在下降。

相似文献

1
Enrollment of women and minorities in NINDS trials.在 NINDS 试验中招募女性和少数族裔。
Neurology. 2011 Jan 25;76(4):354-60. doi: 10.1212/WNL.0b013e3182088260. Epub 2011 Jan 5.
2
Ensuring that the fruits of clinical trial research translate to equitable care.确保临床试验研究成果转化为公平的医疗服务。
Neurology. 2011 Jan 25;76(4):314-5. doi: 10.1212/WNL.0b013e31820c7509. Epub 2011 Jan 5.
3
Race and Ethnicity Reporting and Representation in Pediatric Clinical Trials.儿科临床试验中的种族和族裔报告与呈现
Pediatrics. 2023 Apr 1;151(4). doi: 10.1542/peds.2022-058552.
4
Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs: A Systematic Review.多发性硬化症疾病修正治疗药物Ⅲ期试验中非白人参与者的纳入情况以及种族和族裔报告:一项系统评价
Neurology. 2022 Mar 1;98(9):e880-e892. doi: 10.1212/WNL.0000000000013230. Epub 2022 Jan 19.
5
Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement.三期前列腺癌临床试验中的少数民族招募趋势(2003 年至 2014 年):进展和需要改进的关键领域。
J Urol. 2019 Feb;201(2):259-267. doi: 10.1016/j.juro.2018.09.029.
6
Diversity, Equity, and Inclusion in Urolithiasis Clinical Trials: Representative Enrollment by Race, Ethnicity, and Sex.尿石症临床试验中的多样性、公平性和包容性:按种族、族裔和性别代表性入组。
Urol Pract. 2024 Jul;11(4):685-691. doi: 10.1097/UPJ.0000000000000595. Epub 2024 May 8.
7
Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.种族和少数民族参与前列腺、肺、结肠直肠和卵巢癌筛查试验的情况。
J Natl Med Assoc. 2008 Mar;100(3):291-8. doi: 10.1016/s0027-9684(15)31241-4.
8
Reporting and Representation of Participant Race and Ethnicity in National Institutes of Health-Funded Pediatric Clinical Trials.报告和代表参与者的种族和民族在国立卫生研究院资助的儿科临床试验。
JAMA Netw Open. 2023 Aug 1;6(8):e2331316. doi: 10.1001/jamanetworkopen.2023.31316.
9
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.非裔美国人、西班牙裔和白人在国立癌症研究所癌症治疗试验中的代表性。
J Natl Cancer Inst. 1996 Jun 19;88(12):812-6. doi: 10.1093/jnci/88.12.812.
10
Minorities are under-reported and females are under-represented in stroke motor recovery trials.在中风运动恢复试验中,少数族裔的相关报道不足,女性的代表性不足。
Top Stroke Rehabil. 2025 Mar;32(2):208-212. doi: 10.1080/10749357.2024.2384324. Epub 2024 Jul 29.

引用本文的文献

1
Barriers and facilitators to Parkinson's disease research participation amongst underrepresented groups.帕金森病研究中代表性不足群体参与的障碍与促进因素。
BMC Res Notes. 2025 May 29;18(1):240. doi: 10.1186/s13104-025-07293-1.
2
Fielding the research participant perception survey to evaluate a culturally tailored Latinx cohort study.开展研究参与者认知调查以评估一项文化定制的拉丁裔队列研究。
J Clin Transl Sci. 2024 Oct 29;8(1):e178. doi: 10.1017/cts.2024.629. eCollection 2024.
3
Stem cell therapy: a new hope for stroke and traumatic brain injury recovery and the challenge for rural minorities in South Carolina.干细胞疗法:中风和创伤性脑损伤康复的新希望以及南卡罗来纳州农村少数族裔面临的挑战。
Front Neurol. 2024 Aug 9;15:1419867. doi: 10.3389/fneur.2024.1419867. eCollection 2024.
4
Disability and Recurrent Stroke Among Participants in Stroke Prevention Trials.卒中预防试验中参与者的残疾和复发性卒中。
JAMA Netw Open. 2024 Jul 1;7(7):e2423677. doi: 10.1001/jamanetworkopen.2024.23677.
5
Underrepresented and Underserved Populations in Neurological Research.神经科学研究中的代表性不足和服务不足的人群。
Semin Neurol. 2024 Apr;44(2):168-177. doi: 10.1055/s-0044-1782516. Epub 2024 Mar 14.
6
Disparities in Race and Ethnicity Reporting and Representation for Clinical Trials in Stroke: 2010 to 2020.种族和民族在中风临床试验报告和代表性方面的差异:2010 年至 2020 年。
J Am Heart Assoc. 2024 Mar 19;13(6):e033467. doi: 10.1161/JAHA.123.033467. Epub 2024 Mar 8.
7
Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 Trials.来自边缘化种族和族裔群体的参与者招募:对STEADY-PD III和SURE-PD3试验的比较评估。
Neurol Clin Pract. 2023 Feb;13(1):e200113. doi: 10.1212/CPJ.0000000000200113. Epub 2023 Jan 18.
8
Barriers to Enrollment in Post-Stroke Brain Stimulation in a Racially and Ethnically Diverse Population.在不同种族和民族的人群中,脑刺激治疗卒中后障碍。
Neurorehabil Neural Repair. 2022 Sep;36(9):596-602. doi: 10.1177/15459683221088861. Epub 2022 Aug 4.
9
High tech and high touch: Recruitment strategies for enrolling African American stroke survivors in Community Based Intervention under Nurse Guidance after stroke (CINGS) trial.高科技与高关怀:在卒中后护士指导下的社区干预中招募非裔美国卒中幸存者参与社区卒中干预试验(CINGS)的策略
Contemp Clin Trials Commun. 2021 Sep 8;24:100844. doi: 10.1016/j.conctc.2021.100844. eCollection 2021 Dec.
10
Perceptions and Preferences Regarding Multiple Sclerosis Research Among Racial and Ethnic Groups.种族和族裔群体对多发性硬化症研究的认知与偏好
Int J MS Care. 2021 Jul-Aug;23(4):170-177. doi: 10.7224/1537-2073.2019-131. Epub 2021 Jan 12.

本文引用的文献

1
Engaging members of African American and Latino communities in preventive HIV vaccine trials.让非裔美国人和拉丁裔社区成员参与预防性HIV疫苗试验。
J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):194-201. doi: 10.1097/qai.0b013e3181990605.
2
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes.中风的性别差异:流行病学、临床表现、医疗护理及预后。
Lancet Neurol. 2008 Oct;7(10):915-26. doi: 10.1016/S1474-4422(08)70193-5. Epub 2008 Aug 21.
3
An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials.考察患者种族和族裔对其表达的参与癌症临床试验了解意愿的影响。
J Cancer Res Clin Oncol. 2008 Jan;134(1):115-8. doi: 10.1007/s00432-007-0263-4. Epub 2007 Jun 28.
4
Effect of a US National Institutes of Health programme of clinical trials on public health and costs.美国国立卫生研究院临床试验项目对公众健康和成本的影响。
Lancet. 2006 Apr 22;367(9519):1319-27. doi: 10.1016/S0140-6736(06)68578-4.
5
Effective recruitment and retention of minority research participants.有效招募和留住少数族裔研究参与者。
Annu Rev Public Health. 2006;27:1-28. doi: 10.1146/annurev.publhealth.27.021405.102113.
6
Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors.临床试验的招募与参与:社会人口统计学、城乡及医疗保健可及性预测因素
Cancer Detect Prev. 2006;30(1):24-33. doi: 10.1016/j.cdp.2005.12.001. Epub 2006 Feb 21.
7
Are racial and ethnic minorities less willing to participate in health research?少数族裔参与健康研究的意愿较低吗?
PLoS Med. 2006 Feb;3(2):e19. doi: 10.1371/journal.pmed.0030019. Epub 2005 Dec 6.
8
Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.1988年至2002年美国国立过敏与传染病研究所资助的HIV疫苗试验网络中种族/族裔少数群体的参与情况。
Public Health Rep. 2005 Sep-Oct;120(5):543-8. doi: 10.1177/003335490512000509.
9
Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project.与非西班牙裔白人相比,墨西哥裔美国人中风发生率过高:科珀斯克里斯蒂脑卒中标测项目
Am J Epidemiol. 2004 Aug 15;160(4):376-83. doi: 10.1093/aje/kwh225.
10
Participation in cancer clinical trials: race-, sex-, and age-based disparities.参与癌症临床试验:基于种族、性别和年龄的差异。
JAMA. 2004 Jun 9;291(22):2720-6. doi: 10.1001/jama.291.22.2720.